The post South Korea’s chip giants surge on soaring AI memory demand appeared on BitcoinEthereumNews.com. Top chipmakers in South Korea, SK Hynix and Samsung ElectronicsThe post South Korea’s chip giants surge on soaring AI memory demand appeared on BitcoinEthereumNews.com. Top chipmakers in South Korea, SK Hynix and Samsung Electronics

South Korea’s chip giants surge on soaring AI memory demand

Top chipmakers in South Korea, SK Hynix and Samsung Electronics, are coming up fast as strong demand for AI raises prices and gives the semiconductor industry high expectations of stable long-term profits.

Nvidia needs more high-bandwidth memory chips for its accelerators, forcing its supplier, SK Hynix, to increase production levels. At the same time, Samsung Electronics and Micron Technology are working hard to boost their production capacity to keep up with the growing demand. 

SK Hynix gains as AI memory demand tightens supply

SK Hynix is one of the world’s largest producers of high-bandwidth memory, and the rising demand for AI chips, including from its biggest customer, Nvidia, is putting the company at the center of it all. 

More organizations are building and deploying AI servers that use accelerators to process large amounts of data, raising the demand for advanced memory. SK Hynix sits at the center of global demand as producers struggle to address the short supply.

This rise in demand is taking up space throughout the memory sector, something competitors are beginning to notice. As demand for artificial intelligence grows, so does pressure on manufacturing output – Micron points out that this shift limits the availability of standard devices like phones and laptops.

As a result, shortages are spreading beyond AI chips into everyday memory products, adding pressure on availability while tilting price control toward producers. Because output remains limited and buyer interest holds steady, firms that build memory can increase costs.

With these conditions in mind, SK Hynix turns toward expanding future capabilities through updated infrastructure and upgraded output. 

Construction of a state-of-the-art chip assembly plant is already underway and is designed specifically for intricate AI-driven memory systems demanding refined fabrication methods.

SK Hynix is also interested in a potential US share listing to help lift its valuation and broaden its investor base. 

Samsung makes more profit as memory prices go up

Profits at Samsung are climbing quickly. Higher memory chip prices, along with stronger buyer interest, suggest the industry slump may be ending. At the same time, early data indicate operating profit for the quarter rose 3X compared to last year. This outcome highlights changing dynamics following an extended period of low prices and restrained client purchases.

The high profit is due to strong demand in Samsung’s operating areas, particularly in memory, which has a significant impact on the results. With the growth of AI infrastructure, customers demand more memory, leading the company to raise prices to boost profits.

This rebound takes shape shortly before the firm unveils its fourth-quarter financial report on January 29. This date coincides with SK Hynix’s own announcement, offering market participants a side-by-side view of how both top-tier Korean chip producers ride the same demand currents.

HSBC reported that the growing demand for artificial intelligence systems will enable companies like Samsung to expand production and achieve stable returns for years to come.

These technologies consume significantly more memory than standard computing platforms. As a result, ongoing investments are taking hold at multiple levels within the production network.

This outlook has lifted confidence in both Samsung and SK Hynix, helping push chip-related stocks higher across Asian markets as investors look ahead to a longer period of earnings growth.

Another notable semiconductor is Taiwan Semiconductor Manufacturing Company, which is planning to spend as much as $56 billion on capital in the current fiscal year.

However, the strength comes from trends, as demand for high-end processors remains high due to changing computing requirements.

The smartest crypto minds already read our newsletter. Want in? Join them.

Source: https://www.cryptopolitan.com/korean-chip-giants-surge-on-soaring-demand/

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

U.S. President Donald Trump filed a lawsuit against JPMorgan Chase and its CEO Jamie Dimon personally, accusing the institution of deliberate debanking. The politician
Share
Incrypted2026/01/23 15:59
Here’s why Polygon price is at risk of a 25% plunge

Here’s why Polygon price is at risk of a 25% plunge

Polygon price continued its freefall, reaching its lowest level since April 21, as the broader crypto sell-off gained momentum. Polygon (POL) dropped to $0.1915, down 32% from its highest point in May and 74% below its 2024 peak. The crash…
Share
Crypto.news2025/06/19 00:56
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26